皮拉鲁比辛组合低剂量化疗用于早期婴儿期MS神经母细胞瘤:病例报告
Yutaka Kato1,2, Hiroshi Kawaguchi1, Naoki Sakata2
1Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima-Shi 734-8551, Hiroshima, Japan.
Children (Basel, Switzerland)
|May 27, 2023
概括
一个案例研究突出了婴儿神经母细胞瘤 (NB) 的成功治疗方法. 基于Pirarubicin的化疗有效地减少了MS NB瘤的阶段,导致5年后没有并发症的良好结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症基因组学 癌症基因组学
背景情况:
- 神经母细胞瘤 (NB) 是一种常见的婴儿恶性瘤,结果各不相同.
- 早期诊断和风险分层对于适当的治疗选择至关重要.
更多相关视频
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
